Dr. Cristina Martín Higueras is a prestigious physician and biologist who is highly specialized in the study and analysis of rare diseases, with a particular focus on primary hyperoxaluria. In this sense, her philosophy is based on a firm commitment to the general well-being of patients. This has led her to lead multiple cutting-edge projects to promote both progress and innovation in healthcare. She has spent most of her career working as a research scientist in internationally renowned institutions, such as the University Hospital of Bonn in Germany.

With regard to her line of inquiry, she has focused on subjects ranging from the molecular mechanisms involved in metabolic disorders to the development of new therapies to optimize the quality of life of individuals. In turn, her work also includes the management of state-of-the-art biotechnological tools such as genetic editing, experimental models and even computational software for modeling. These findings have been fundamental in increasing understanding of rare pathologies, including Congenital Adrenal Hyperplasia. Thanks to this, she has contributed to the design of pioneering therapeutic solutions that are more personalized and effective.

• Researcher at the Institute of Experimental Immunology at the University Hospital of Bonn
• Founder of PHHP Team

• Scientific Consultant for Novo Nordisk

• Promoter of the European Association of Patients with Hyperozaluria

• Biomedical Researcher at Orphan Biotech

• Advisor to Meta Pharmaceuticals

• PhD in Biomedical Sciences from the University of La Laguna

• Master's Degree in Molecular Biomedicine from the Autonomous University of Madrid

• Degree in Medicine from the University of La Laguna

• Bachelor's Degree in Biology from the University of La Laguna

• Member of the OxalEurope Foundation

• Certification in Animal Experimentation